Alterations in the expression of serum-derived exosome-enclosed inflammatory microRNAs in Covid-19 patients.

Publication date: Oct 30, 2024

MicroRNAs in exosomes play a role in biological processes such as inflammation and Epithelial-mesenchymal transition (EMT). In EMT, epithelial cells undergo phenotypic changes and become similar to mesenchymal cells. EMT increases the invasion and metastasis of cancer cells. We aimed to evaluate the expression levels of miRNA-21, miRNA-218, miRNA-155, and miRNA-10b, which are effective in the pathway of inflammation and EMT in serum-derived exosome of COVID-19 patients. Blood samples were taken from 30 patients with COVID-19 and five healthy individuals as a control group. After separating the serum from the collected blood, the exosomes were purified from the serum. Relative expression of microRNAs was measured by real-time PCR method. The relative expression of miRNA-21, miRNA-218, and miRNA-155 in serum-derived exosomes of patients with COVID-19 had a significant increase (p

Concepts Keywords
10b COVID-19
Covid Extracellular Vesicles
Inflammatory miRNA-10b
Pcr miRNA-155
miRNA-21
miRNA-218

Semantics

Type Source Name
disease MESH Covid-19
disease IDO role
disease MESH inflammation
disease MESH metastasis
disease MESH cancer
disease IDO blood

Original Article

(Visited 1 times, 1 visits today)